Loading...
•
Jun 30, 2020
OrthoPediatrics Q2 2020 Earnings Report
OrthoPediatrics experienced a revenue decline due to the COVID-19 pandemic but showed monthly improvement and advanced key initiatives.
Key Takeaways
OrthoPediatrics Corp. reported a 25.3% decrease in total revenue for Q2 2020, totaling $13.6 million, compared to $18.2 million in Q2 2019. The decline was primarily due to the impact of the COVID-19 pandemic. Despite the decrease, the company saw significant monthly improvement throughout the quarter and continued to execute key initiatives, including the acquisition and launch of the ApiFix system.
Total revenue for Q2 2020 was $13.6 million, a 25.3% decrease compared to Q2 2019.
U.S. revenue decreased by 12.3% compared to the same period last year.
The company commenced the initial U.S. launch of the ApiFix system following its acquisition.
The domestic sales organization expanded to 164 consultants, a 7.9% increase from Q2 2019.
OrthoPediatrics
OrthoPediatrics
OrthoPediatrics Revenue by Segment
OrthoPediatrics Revenue by Geographic Location
Revenue by Segment
Trauma & Deformity Revenue
CapyFin.comScoliosis Revenue
CapyFin.comSports Medicine/Other Revenue
CapyFin.comRevenue by Geographic Location
U.S. Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
OrthoPediatrics maintains suspension of its revenue growth and set consignment guidance for the full year 2020 due to the rapidly evolving environment and continued uncertainties surrounding the duration and impact of COVID-19.
Revenue & Expenses
Visualization of income flow from segment revenue to net income